share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Director FARAH ROGER N

CVS Health | 4: Statement of changes in beneficial ownership of securities-Director FARAH ROGER N

西维斯健康 | 4:持股变动声明-董事 FARAH ROGER N
美股sec公告 ·  05/18 05:43
牛牛AI助手已提取核心信息
On May 16, 2024, Roger N. Farah, associated with CVS Health Corp [CVS], reported a transaction involving the company's common stock. The action, which was direct in nature, resulted in Farah holding a total of 4,124.4534 shares of CVS Health's common stock. The transaction details, including the number of shares involved and the price per share, were not disclosed in the announcement. Investors now have updated information on Farah's stake in CVS Health, which may influence their investment decisions regarding CVS stock.
On May 16, 2024, Roger N. Farah, associated with CVS Health Corp [CVS], reported a transaction involving the company's common stock. The action, which was direct in nature, resulted in Farah holding a total of 4,124.4534 shares of CVS Health's common stock. The transaction details, including the number of shares involved and the price per share, were not disclosed in the announcement. Investors now have updated information on Farah's stake in CVS Health, which may influence their investment decisions regarding CVS stock.
2024年5月16日,与CVS Health Corp [CVS] 相关的罗杰·法拉报告了一笔涉及该公司普通股的交易。该行动本质上是直接的,导致法拉共持有CVS Health的4,124.4534股普通股。公告中未披露交易细节,包括所涉及的股票数量和每股价格。投资者现在已经更新了有关法拉在CVS Health的股份的信息,这可能会影响他们对CVS股票的投资决策。
2024年5月16日,与CVS Health Corp [CVS] 相关的罗杰·法拉报告了一笔涉及该公司普通股的交易。该行动本质上是直接的,导致法拉共持有CVS Health的4,124.4534股普通股。公告中未披露交易细节,包括所涉及的股票数量和每股价格。投资者现在已经更新了有关法拉在CVS Health的股份的信息,这可能会影响他们对CVS股票的投资决策。

译文内容由第三方软件翻译。


牛牛AI助手部分由第三方人工智能模型基于资讯内容自动生成,只对中国内地以外的地区提供。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。